1 - 25 of
33
results
for author:"Webb T."
in Literature Citations
| Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. Webb T.J., Bieler J.G., Schneck J.P., Oelke M. J. Immunol. Methods 346:38-44(2009) · Mapped (1) |
| X-linked cataract and Nance-Horan syndrome are allelic disorders. Coccia M., Brooks S.P., Webb T.R., Christodoulou K., Wozniak I.O., Murday V., Balicki M., Yee H.A., Wangensteen T., Riise R. et al. Hum. Mol. Genet. 18:2643-2655(2009) · Mapped (3) |
| MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Chan L.F., Webb T.R., Chung T.T., Meimaridou E., Cooray S.N., Guasti L., Chapple J.P., Egertova M., Elphick M.R., Cheetham M.E. et al. Proc. Natl. Acad. Sci. U.S.A. 106:6146-6151(2009) · Mapped (2) |
| The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Parfitt D.A., Michael G.J., Vermeulen E.G., Prodromou N.V., Webb T.R., Gallo J.M., Cheetham M.E., Nicoll W.S., Blatch G.L., Chapple J.P. Hum. Mol. Genet. 18:1556-1565(2009) · Mapped (4) |
| Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Mead S., Poulter M., Uphill J., Beck J., Whitfield J., Webb T.E., Campbell T., Adamson G., Deriziotis P., Tabrizi S.J. et al. Lancet Neurol 8:57-66(2009) · Mapped (27) |
| The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development. Sharp T.V., Al-Attar A., Foxler D.E., Ding L., de A Vallim T.Q., Zhang Y., Nijmeh H.S., Webb T.M., Nicholson A.G., Zhang Q. et al. Proc. Natl. Acad. Sci. U.S.A. 105:19932-19937(2008) · Mapped (7) |
| Activating mutations in ALK provide a therapeutic target in neuroblastoma. George R.E., Sanda T., Hanna M., Frohling S., Luther W., Zhang J., Ahn Y., Zhou W., London W.B., McGrady P. et al. Nature 455:975-978(2008) · Mapped (13) |
| The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. Chung T.T., Webb T.R., Chan L.F., Cooray S.N., Metherell L.A., King P.J., Chapple J.P., Clark A.J. J. Clin. Endocrinol. Metab. 93:4948-4954(2008) · Mapped (2) |
| Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking. Webb T.R., Chan L., Cooray S.N., Cheetham M.E., Chapple J.P., Clark A.J. Endocrinology 150:720-726(2009) · Mapped (3) |
| Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development. Webb T.R., Cross S.H., McKie L., Edgar R., Vizor L., Harrison J., Peters J., Jackson I.J. J. Cell. Sci. 121:3140-3145(2008) · Mapped (30) |
| Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival. Spendlove I., Al-Attar A., Watherstone O., Webb T.M., Ellis I.O., Longmore G.D., Sharp T.V. Int. J. Cancer 123:2247-2253(2008) · Mapped (1) |
| Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases. Isaacs A.M., Powell C., Webb T.E., Linehan J.M., Collinge J., Brandner S. Neuropathol. Appl. Neurobiol. 34:446-456(2008) · Mapped (10) |
| Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung. Chiyo M., Iwata T., Webb T.J., Vasko M.R., Thompson E.L., Heidler K.M., Cummings O.W., Yoshida S., Fujisawa T., Brand D.D. et al. Am. J. Transplant. 8:537-546(2008) · Mapped (1) |
| Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. Mead S., Webb T.E., Campbell T.A., Beck J., Linehan J.M., Rutherfoord S., Joiner S., Wadsworth J.D., Heckmann J., Wroe S. et al. Neurology 69:730-738(2007) · Mapped (18) |
| Patterns of somatic mutation in human cancer genomes. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C. et al. Nature 446:153-158(2007) · UniProtKB (453) |
| Analysis of candidate imprinted genes in PWS subjects with atypical genetics: a possible inactivating mutation in the SNURF/SNRPN minimal promoter. Maina E.N., Webb T., Soni S., Whittington J., Boer H., Clarke D., Holland A. J. Hum. Genet. 52:297-307(2007) · Mapped (8) |
| Dendritic cell-T cell interactions: CD8 alpha alpha expressed on dendritic cells regulates T cell proliferation. Hong L., Webb T.J., Wilkes D.S. Immunol. Lett. 108:174-178(2007) · Mapped (9) |
| Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Field M.J., Cox P.J., Stott E., Melrose H., Offord J., Su T.Z., Bramwell S., Corradini L., England S., Winks J. et al. Proc. Natl. Acad. Sci. U.S.A. 103:17537-17542(2006) · Mapped (4) |
| Synergy among differentially regulated repressors of the ribonucleotide diphosphate reductase genes of Saccharomyces cerevisiae. Klinkenberg L.G., Webb T., Zitomer R.S. Eukaryotic Cell 5:1007-1017(2006) · Mapped (6) |
| Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. Renukaradhya G.J., Webb T.J., Khan M.A., Lin Y.L., Du W., Gervay-Hague J., Brutkiewicz R.R. J. Immunol. 175:4301-4308(2005) · Mapped (6) |
| Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex. Hainsworth A.H., Bermpohl D., Webb T.E., Darwish R., Fiskum G., Qiu J., McCarthy D., Moskowitz M.A., Whalen M.J. J. Cereb. Blood Flow Metab. 25:1030-1040(2005) · Mapped (11) |
| Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Wayman C., Phillips S., Lunny C., Webb T., Fawcett L., Baxendale R., Burgess G. Int. J. Impot. Res. 17:216-223(2005) · UniProtKB (1) |
| Flt3-ligand, IL-4, GM-CSF, and adherence-mediated isolation of murine lung dendritic cells: assessment of isolation technique on phenotype and function. Swanson K.A., Zheng Y., Heidler K.M., Zhang Z.D., Webb T.J., Wilkes D.S. J. Immunol. 173:4875-4881(2004) · Mapped (8) |
| Functional characterization of a P2X receptor from Schistosoma mansoni. Agboh K.C., Webb T.E., Evans R.J., Ennion S.J. J. Biol. Chem. 279:41650-41657(2004) · UniProtKB (1) |
| Regulation of rat hepatocyte function by P2Y receptors: focus on control of glycogen phosphorylase and cyclic AMP by 2-methylthioadenosine 5'-diphosphate. Dixon C.J., Hall J.F., Webb T.E., Boarder M.R. J. Pharmacol. Exp. Ther. 311:334-341(2004) · Mapped (2) |
